These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22768436)

  • 21. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
    Dalle S; Thomas L
    Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of patch type mycosis fungoides with tacrolimus ointment 0.1%.
    Rallis E; Economidi A; Verros C; Papadakis P
    J Drugs Dermatol; 2006 Oct; 5(9):906-7. PubMed ID: 17039660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycosis fungoides.
    Zinzani PL; Ferreri AJ; Cerroni L
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):172-82. PubMed ID: 17950613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
    Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
    J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
    Ponte P; Serrão V; Apetato M
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases.
    Muniesa C; Estrach T; Pujol RM; Gallardo F; Garcia-Muret P; Climent J; Servitje O
    J Am Acad Dermatol; 2010 Mar; 62(3):418-26. PubMed ID: 20079954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC).
    Kempf W; Ostheeren-Michaelis S; Paulli M; Lucioni M; Wechsler J; Audring H; Assaf C; Rüdiger T; Willemze R; Meijer CJ; Berti E; Cerroni L; Santucci M; Hallermann C; Berneburg M; Chimenti S; Robson A; Marschalko M; Kazakov DV; Petrella T; Fraitag S; Carlotti A; Courville P; Laeng H; Knobler R; Golling P; Dummer R; Burg G;
    Arch Dermatol; 2008 Dec; 144(12):1609-17. PubMed ID: 19075143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long-term follow-up in forty-three patients.
    Rosenbaum MM; Roenigk HH; Caro WA; Esker A
    J Am Acad Dermatol; 1985 Oct; 13(4):613-22. PubMed ID: 3878369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual variants of mycosis fungoides.
    Abeldaño A; Arias M; Benedetti A; Ochoa K; Maskin M; Pellerano G; Kien MC; Chouela E
    Skinmed; 2011; 9(4):218-22. PubMed ID: 21980706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
    Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poikilodermatous Mycosis Fungoides - Rare Entity, Different Treatment Modalities.
    Jerković Gulin S; Čeović R; Ilić I; Bradamante M; Bukvić Mokos Z; Kostović K
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):48-52. PubMed ID: 29782300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
    Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
    Olsen E; Vonderheid E; Pimpinelli N; Willemze R; Kim Y; Knobler R; Zackheim H; Duvic M; Estrach T; Lamberg S; Wood G; Dummer R; Ranki A; Burg G; Heald P; Pittelkow M; Bernengo MG; Sterry W; Laroche L; Trautinger F; Whittaker S;
    Blood; 2007 Sep; 110(6):1713-22. PubMed ID: 17540844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
    Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
    J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of pigmented purpuric dermatosis and mycosis fungoides: atypical T-cell dyscrasia.
    Ladrigan MK; Poligone B
    Cutis; 2014 Dec; 94(6):297-300. PubMed ID: 25566571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photochemotherapy for mycosis fungoides.
    Roenigk HH
    Arch Dermatol; 1977 Aug; 113(8):1047-51. PubMed ID: 889332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.